Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy A Davis

Showing results (11-20 of 179) with videos related to

Pageof 18
Sort By:
Journal of Diabetes and Its Complications|April 21, 2019
The LEADER trial in type 2 diabetes: Were the characteristics and outcomes of the participants representative?Timothy M E Davis, Wendy A Davis
The New England Journal of Medicine|March 8, 2018
Hearing Loss in AdultsTimothy ME Davis, Wendy A Davis, Michael Hunter
Internal Medicine Journal|October 11, 2017
Pneumococcal vaccination and incident hospitalisation for pneumonia in type 2 diabetes: the Fremantle Diabetes Study Phase IITimothy M E Davis, Jane Kauhanen, Wendy A Davis
Cardiovascular Diabetology|March 19, 2024
Prevalence and prognostic significance of cardiac autonomic neuropathy in community-based people with type 2 diabetes: the Fremantle Diabetes Study Phase IITimothy M E Davis, Eva Tan, Wendy A Davis
The Journal of Clinical Endocrinology and Metabolism|November 6, 2023
Temporal Trends in Distal Symmetric Polyneuropathy in Type 2 Diabetes: The Fremantle Diabetes StudyWendy A Davis, Emma Hamilton, Timothy M E Davis
Journal of Diabetes and Its Complications|July 19, 2024
Effect of prior gestational diabetes on the risk of cardiovascular disease and death in women with type 2 diabetes: The Fremantle Diabetes Study Phase IIEmily Gianatti, Wendy A Davis, Timothy M E Davis
Diabetes Care|November 18, 2009
Aspirin is associated with reduced cardiovascular and all-cause mortality in type 2 diabetes in a primary prevention setting: the Fremantle Diabetes studyGreg Ong, Timothy M E Davis, Wendy A Davis
Heart, Lung & Circulation|February 11, 2015
Re: Essential service standards for equitable national cardiovascular care for Aboriginal and Torres Strait Islander peopleTimothy M E Davis, Wendy A Davis, Daniel McAullay
BMJ Open Diabetes Research & Care|July 24, 2023
Comparative mortality and its determinants in community-based people with type 1 diabetes: the Fremantle Diabetes Study Phase IRuwani Rajapaksa, Wendy A Davis, Timothy M E Davis
The Medical Journal of Australia|February 18, 2009
Comparison of the Framingham and United Kingdom Prospective Diabetes Study cardiovascular risk equations in Australian patients with type 2 diabetes from the Fremantle Diabetes StudyWendy A Davis, Stephen Colagiuri, Timothy M E Davis
Pageof 18

Showing results (11-20 of 179) with videos related to

Sort By:
Pageof 18
Journal of Diabetes and Its Complications|April 21, 2019
The LEADER trial in type 2 diabetes: Were the characteristics and outcomes of the participants representative?Timothy M E Davis, Wendy A Davis
The New England Journal of Medicine|March 8, 2018
Hearing Loss in AdultsTimothy ME Davis, Wendy A Davis, Michael Hunter
Internal Medicine Journal|October 11, 2017
Pneumococcal vaccination and incident hospitalisation for pneumonia in type 2 diabetes: the Fremantle Diabetes Study Phase IITimothy M E Davis, Jane Kauhanen, Wendy A Davis
Cardiovascular Diabetology|March 19, 2024
Prevalence and prognostic significance of cardiac autonomic neuropathy in community-based people with type 2 diabetes: the Fremantle Diabetes Study Phase IITimothy M E Davis, Eva Tan, Wendy A Davis
The Journal of Clinical Endocrinology and Metabolism|November 6, 2023
Temporal Trends in Distal Symmetric Polyneuropathy in Type 2 Diabetes: The Fremantle Diabetes StudyWendy A Davis, Emma Hamilton, Timothy M E Davis
Journal of Diabetes and Its Complications|July 19, 2024
Effect of prior gestational diabetes on the risk of cardiovascular disease and death in women with type 2 diabetes: The Fremantle Diabetes Study Phase IIEmily Gianatti, Wendy A Davis, Timothy M E Davis
Diabetes Care|November 18, 2009
Aspirin is associated with reduced cardiovascular and all-cause mortality in type 2 diabetes in a primary prevention setting: the Fremantle Diabetes studyGreg Ong, Timothy M E Davis, Wendy A Davis
Heart, Lung & Circulation|February 11, 2015
Re: Essential service standards for equitable national cardiovascular care for Aboriginal and Torres Strait Islander peopleTimothy M E Davis, Wendy A Davis, Daniel McAullay
BMJ Open Diabetes Research & Care|July 24, 2023
Comparative mortality and its determinants in community-based people with type 1 diabetes: the Fremantle Diabetes Study Phase IRuwani Rajapaksa, Wendy A Davis, Timothy M E Davis
The Medical Journal of Australia|February 18, 2009
Comparison of the Framingham and United Kingdom Prospective Diabetes Study cardiovascular risk equations in Australian patients with type 2 diabetes from the Fremantle Diabetes StudyWendy A Davis, Stephen Colagiuri, Timothy M E Davis
Pageof 18